M2 PRESSWIRE-April 25, 2017-Influenza Vaccine Market (Italy, Malta, Portugal & Spain) – Italy & Spain to Share More than 90% of the Market by 2022
(C)1994-2017 M2 COMMUNICATIONS
RDATE:25042017
Dublin – Research and Markets has announced the addition of the “Influenza Vaccine Market in Italy, Malta, Portugal and Spain (South Europe) By (Child & Adult) Forecast” report to their offering.
According to this report ‘Influenza Vaccine Market in Italy, Malta, Portugal and Spain (South Europe) By (Child & Adult) Forecast’, in the Southern European countries, Italy is having the highest seasonal influenza vaccine market share followed by Spain. In terms of children vaccination, Italy & Spain holds more than 80 percent market share whereas, in adult vaccination segments, these two will share more than 90 percent market share by 2022.
This report provides a complete analysis of 4 Southern European Countries (Italy, Malta, Portugal and Spain) Seasonal Influenza Vaccine Market (Child & Adult), Number of Vaccinated Population (Child & Adult) and Forecast till 2022.
Growth Drivers:
– Vaccine Manufacturers Plan to Increase Flu Vaccine Production
– Declining Child Population & Accelerating Ageing Population in Southern European Region
– Rising Healthcare Expenditure Share of the Southern Europe Countries GDP
Challenges:
– Regulatory Challenges with New and Novel Influenza Vaccines
– Lack of Healthcare Infrastructure
– Limited Reimbursement and Access to the Vaccines
Countries Covered
– Italy
– Malta
– Portugal
– Spain
Key Topics Covered:
1. Executive Summary
2. Southern European Countries Seasonal Influenza Vaccinated Total Population
3. Southern European Countries Seasonal Influenza Vaccine Market s
4. Southern Europe Countries Seasonal Influenza Vaccine Market Share
5. Italy
6. Malta
7. Portugal
8. Spain
9. Seasonal Influenza Vaccine – Growth Drivers
10. Seasonal Influenza Vaccine – Challenges
For more information about this report visit http://www.researchandmarkets.com/research/xdq8sq/influenza_vaccine